Ignite Creation Date:
2024-05-05 @ 9:51 PM
Last Modification Date:
2024-10-26 @ 10:10 AM
Study NCT ID:
NCT00972257
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2009-09-03
Brief Title:
24-hr Intraocular Pressure Control With DorzolamideTimolol vs the BrimonidineTimolol Fixed Combination
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Aristotle University Of Thessaloniki
Study Overview
Official Title:
Quality of 24-hour Intraocular Pressure Control Obtained With DorzolamideTimolol Fixed Combination DTFC Compared With the BrimonidineTimolol Fixed Combination BTFC in Subjects With Primary Open-angle Glaucoma
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The proposed study will compare for the first time the quality of 24-hour IOP control with BrimonidineTimolol fixed combination BTFC versus DorzolamideTimolol fixed combination DTFC after a run-in period of 2 months with timolol This crossover comparison may determine the real efficacy of the two fixed combinations and the design of the proposed study may explain for the first time why the 24-hour IOP reduction provided by BTFC is less than might be anticipated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None